Lymph node stromal cells coordinate immune cell environments during Aspergillus fumigatus infection
烟曲霉感染期间淋巴结基质细胞协调免疫细胞环境
基本信息
- 批准号:10751936
- 负责人:
- 金额:$ 5.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAdoptive TransferAffectAllergic Bronchopulmonary AspergillosisAnatomyAntifungal AgentsAntigen-Presenting CellsAntigensAntimicrobial ResistanceAspergillosisAspergillusAspergillus fumigatusCCL20 geneCCR6 geneCD4 Positive T LymphocytesCXCL10 geneCXCL9 geneCXCR3 geneCell CommunicationCell Differentiation processCell physiologyCellsChronicCompetenceCritical IllnessCuesDataDevelopmentDiseaseDissectionDissociationEffector CellEnvironmentEpigenetic ProcessExhibitsGene TargetingGeneticGoalsHealthHost DefenseHumanImage AnalysisImmuneImmune System DiseasesImmune responseImmunityImmunobiologyImmunofluorescence ImmunologicImmunofluorescence MicroscopyImmunologic Deficiency SyndromesInfectionInflammatoryKnowledgeLifeLigandsLymphocyteLymphoid TissueMapsMediastinal lymph node groupMethodsMicroscopyModificationMolecularMusMycosesNeighborhoodsPatientsPatternPhysiciansPopulationPositioning AttributePrimary InfectionProcessPropertyProteinsResolutionRespiratory Tract InfectionsReticular CellRoleScientistSignal TransductionSourceStromal CellsSystemT cell differentiationT cell responseT-LymphocyteT-Lymphocyte SubsetsTestingTherapeuticTrainingVaccinesadaptive immune responseadaptive immunitycell typechemokinechemokine receptorclinically relevantconfocal imagingcytokinedesigndimensional analysisdraining lymph nodeeffector T cellexperiencehuman diseaseimaging approachimmunomodulatory strategyimproved outcomeinsightlymph node microenvironmentlymph nodesmembermemory retentionmortalitymouse modelnovelnovel strategiesnovel therapeutic interventionpathogenpathogenic fungusreceptorresponsesecondary lymphoid organsegregationsingle-cell RNA sequencingspatiotemporaltherapy developmenttooltraffickingtranscriptomic profilingtranscriptomicsvaccine development
项目摘要
Project Summary
The opportunistic fungal pathogen Aspergillus fumigatus presents a major health concern in immunodeficient
and critically ill patients, with invasive disease contributing to high mortality rates. Infection with A. fumigatus
elicits a diverse adaptive CD4 T cell response. Our preliminary data have demonstrated distinct TH1 and TH17
spatial neighborhoods within mediastinal lymph nodes (LNs) during A. fumigatus airway infection. This spatial
organization positions activated CD4 T cells to receive tailored signals (e.g., antigens, cytokines) for optimal
effector cell differentiation and function. Lymph node stromal cells (LNSCs) are known to provide guidance cues
for immune cell trafficking during monotypic effector T cell responses. However, the mechanisms by which
distinct TH1 and TH17 microenvironments are concurrently established within LNs remain unknown. Defining
these mechanisms will offer insights into the functional importance of LN microenvironments in establishing
human immunity to infection and inflammatory disorders for the identification of novel therapeutic strategies.
Based upon our single-cell RNA-sequencing and flow cytometric analyses of FRC and effector T cell subsets
during A. fumigatus challenge, we propose that (i) FRC subsets establish spatially distinct TH1 and TH17
neighborhoods by dynamically regulating chemotactic receptor-ligand axes, such as
CXCR3:CXCL9/CXCL10 and CCR6:CCL20 and that ii) these neighborhoods can persist after pathogen
clearance. We will address these hypotheses in a clinically relevant murine model of invasive pulmonary
aspergillosis. In Specific Aim 1, we will characterize distinct spatiotemporal microenvironments formed by CD4
T cells and FRCs in A. fumigatus infection by applying spatial transcriptomic profiling followed by high-content
immunofluorescence methods paired with a novel computational approach for image analysis. In Specific Aim
2, we will define the functional role of CD4 T cell spatial organization in A. fumigatus infection by perturbing FRC-
dependent chemokine gradients in a cell type-dependent manner using FRC-specific gene targeting. We will
also conduct adoptive co-transfers of A. fumigatus-specific CD4 T cells sufficient and deficient in CXCR3 and
CCR6. In Specific Aim 3, we will investigate the durability of infection-driven spatial FRC diversity by studying
epigenetic modifications in A. fumigatus-experienced FRCs. We will also employ high-content confocal imaging
to determine whether prior infections affect FRC formation of T cell neighborhoods in subsequent infections. This
study employs and develops novel genetic tools, microscopy methods, and computational approaches to
generate a systems level understanding of secondary lymphoid organ immunobiology. Furthermore, this
proposal is tailored for a physician-scientist in training as it investigates the mechanisms by which stromal cells
induce adaptive immunity to the clinically relevant pathogen A. fumigatus, with implications for anti-fungal
therapeutic strategies and vaccine development.
项目摘要
机会性真菌病原体烟曲霉提出了一个主要的健康问题,在免疫缺陷
和重症患者,侵袭性疾病导致高死亡率。感染A.烟曲霉
激发多样的适应性CD 4 T细胞应答。我们的初步数据表明,不同的TH 1和TH 17
纵隔淋巴结(LN)内的空间邻域在A.烟曲霉呼吸道感染这种空间
组织定位活化的CD 4 T细胞以接收定制的信号(例如,抗原、细胞因子),
效应细胞分化和功能。淋巴结基质细胞(LNSCs)是已知的提供指导线索
在单型效应T细胞应答期间的免疫细胞运输。然而,
不同的TH 1和TH 17微环境同时建立在LN内仍然未知。限定
这些机制将提供深入了解LN微环境的功能重要性,
人类对感染和炎性疾病的免疫力,用于鉴定新的治疗策略。
基于我们对FRC和效应T细胞亚群的单细胞RNA测序和流式细胞术分析,
在A. fumigatus挑战,我们建议(i)FRC亚群建立空间上不同的TH 1和TH 17
通过动态调节趋化性受体-配体轴,如
CXCR 3:CXCL 9/CXCL 10和CCR 6:CCL 20,并且ii)这些邻近区可以在病原体感染后持续存在,
间隙我们将在临床相关的侵袭性肺动脉高压小鼠模型中阐述这些假设。
曲霉病在具体目标1中,我们将描述CD 4形成的不同时空微环境,
T细胞和FRC在A.通过应用空间转录组学分析,
免疫荧光方法与图像分析的新计算方法配对。具体目标
2、明确CD 4 T细胞空间结构在A.通过干扰FRC-
使用FRC特异性基因靶向,以细胞类型依赖性的方式使用依赖性趋化因子梯度。我们将
也进行A的收养共同转移。CXCR 3充足和缺乏的烟曲霉特异性CD 4 T细胞,
CCR 6。在具体目标3中,我们将通过研究感染驱动的空间FRC多样性的持久性,
表观遗传修饰A.经历过烟毒的FRC。我们还将采用高内涵的共聚焦成像
以确定先前感染是否影响后续感染中T细胞邻域的FRC形成。这
研究采用并开发了新型遗传工具、显微镜方法和计算方法,
产生一个系统水平的次级淋巴器官免疫生物学的理解。而且这
该提案是专为一个医生,科学家在培训,因为它调查的机制,基质细胞
诱导对临床相关病原体A的适应性免疫。烟曲霉,与抗真菌的影响
治疗策略和疫苗开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cheryl Mai其他文献
Cheryl Mai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 5.26万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 5.26万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 5.26万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 5.26万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 5.26万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 5.26万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 5.26万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 5.26万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 5.26万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 5.26万 - 项目类别: